TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs4713693
log Bayes Factor = 0.0453509
Chromosome 6   position 33,817,929  (GRCh37) Explore rs4713693 on Ensembl!
Variant rs4713693 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T43.2 Other and unspecified antidepressants
0.191 0.809 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.191 0.809 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.190 0.810 0.000
T36-T50 Poisoning by drugs, medicaments and biological substances
0.186 0.814 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.181 0.819 0.000
T42.4 Benzodiazepines
0.180 0.820 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.162 0.838 0.000
T43.0 Tricyclic and tetracyclic antidepressants
0.159 0.841 0.000
T36 Poisoning by systemic antibiotics
0.158 0.841 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.158 0.842 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.157 0.843 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.151 0.849 0.000
T42.0 Hydantoin derivatives
0.150 0.850 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.150 0.850 0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.146 0.854 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.146 0.854 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.145 0.855 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.145 0.855 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.141 0.859 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.137 0.863 0.000
T42.2 Succinimides and oxazolidinediones
0.137 0.863 0.000
T43.9 Psychotropic drug, unspecified
0.137 0.863 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.137 0.863 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.134 0.866 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.134 0.866 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.133 0.867 0.000
T42.3 Barbiturates
0.132 0.868 0.000
T36.3 Macrolides
0.132 0.868 0.000
T42.1 Iminostilbenes
0.131 0.869 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.128 0.871 0.000
T36.8 Other systemic antibiotics
0.126 0.874 0.000
T40.2 Other opioids
0.124 0.876 0.000
T43.6 Psychostimulants with abuse potential
0.124 0.876 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.124 0.876 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.122 0.878 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.121 0.879 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.121 0.879 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.118 0.882 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.117 0.883 0.000
T36.0 Penicillins
0.116 0.884 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.115 0.885 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.114 0.886 0.000
T36.9 Systemic antibiotic, unspecified
0.114 0.886 0.000
T36.7 Antifungal antibiotics, systemically used
0.114 0.886 0.000
T36.6 Rifamycins
0.114 0.886 0.000
T36.5 Aminoglycosides
0.114 0.886 0.000
T36.2 Chloramphenicol group
0.114 0.886 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.114 0.886 0.000
T40.4 Other synthetic narcotics
0.114 0.886 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.113 0.886 0.000
T46.7 Peripheral vasodilators
0.113 0.886 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.113 0.886 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.113 0.886 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.113 0.886 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.110 0.890 0.000
T36.4 Tetracyclines
0.110 0.890 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.110 0.890 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.109 0.891 0.000
T45.5 Anticoagulants
0.108 0.892 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.108 0.892 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.108 0.892 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.108 0.892 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.108 0.892 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.108 0.892 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.108 0.892 0.000
T44.0 Anticholinesterase agents
0.108 0.892 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.107 0.893 0.000
T37.5 Antiviral drugs
0.107 0.893 0.000
T37.4 Anthelminthics
0.107 0.893 0.000
T37.3 Other antiprotozoal drugs
0.107 0.893 0.000
T37.1 Antimycobacterial drugs
0.107 0.893 0.000
T37.0 Sulphonamides
0.107 0.893 0.000
T40.1 Heroin
0.106 0.894 0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.105 0.895 0.000
T40.8 Lysergide [LSD]
0.105 0.895 0.000
T40.7 Cannabis (derivatives)
0.105 0.895 0.000
T40.3 Methadone
0.105 0.895 0.000
T40.0 Opium
0.105 0.895 0.000
T40.5 Cocaine
0.103 0.897 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.102 0.898 0.000
T38.1 Thyroid hormones and substitutes
0.098 0.901 0.000
T41.5 Therapeutic gases
0.096 0.904 0.000
T41.4 Anaesthetic, unspecified
0.096 0.904 0.000
T41.3 Local anaesthetics
0.096 0.904 0.000
T41.2 Other and unspecified general anaesthetics
0.096 0.904 0.000
T41.1 Intravenous anaesthetics
0.096 0.904 0.000
T41.0 Inhaled anaesthetics
0.096 0.904 0.000
T49.9 Topical agent, unspecified
0.096 0.904 0.000
T49.8 Other topical agents
0.096 0.904 0.000
T49.7 Dental drugs, topically applied
0.096 0.904 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.096 0.904 0.000
T49.5 Ophthalmological drugs and preparations
0.096 0.904 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.096 0.904 0.000
T49.3 Emollients, demulcents and protectants
0.096 0.904 0.000
T49.2 Local astringents and local detergents
0.096 0.904 0.000
T49.1 Antipruritics
0.096 0.904 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.096 0.904 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.095 0.905 0.000
T48.5 Anti-common-cold drugs
0.095 0.905 0.000
T48.4 Expectorants
0.095 0.905 0.000
T48.3 Antitussives
0.095 0.905 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.095 0.905 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.095 0.905 0.000
T48.0 Oxytocic drugs
0.095 0.905 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.094 0.906 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.092 0.908 0.000
T45.8 Other primarily systemic and haematological agents
0.092 0.908 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.092 0.908 0.000
T45.6 Fibrinolysis-affecting drugs
0.092 0.908 0.000
T45.4 Iron and its compounds
0.092 0.908 0.000
T45.3 Enzymes, not elsewhere classified
0.092 0.908 0.000
T45.2 Vitamins, not elsewhere classified
0.092 0.908 0.000
T45.0 Antiallergic and antiemetic drugs
0.092 0.908 0.000
T47.2 Stimulant laxatives
0.088 0.912 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.087 0.913 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.087 0.913 0.000
T47.7 Emetics
0.087 0.913 0.000
T47.6 Antidiarrhoeal drugs
0.087 0.913 0.000
T47.5 Digestants
0.087 0.913 0.000
T47.3 Saline and osmotic laxatives
0.087 0.913 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.086 0.914 0.000
T47.0 Histamine H(2)-receptor antagonists
0.085 0.915 0.000
T50.8 Diagnostic agents
0.084 0.916 0.000
T38.9 Other and unspecified hormone antagonists
0.082 0.918 0.000
T38.7 Androgens and anabolic congeners
0.082 0.918 0.000
T38.5 Other oestrogens and progestogens
0.082 0.918 0.000
T38.4 Oral contraceptives
0.082 0.918 0.000
T38.2 Antithyroid drugs
0.082 0.918 0.000
T38.0 Glucocorticoids and synthetic analogues
0.082 0.918 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.082 0.918 0.000
T50.4 Drugs affecting uric acid metabolism
0.081 0.919 0.000
T47.4 Other laxatives
0.081 0.919 0.000
T46.1 Calcium-channel blockers
0.080 0.920 0.000
T40.6 Other and unspecified narcotics
0.080 0.920 0.000
T50.7 Analeptics and opioid receptor antagonists
0.078 0.922 0.000
T50.5 Appetite depressants
0.078 0.922 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.078 0.922 0.000
T50.1 Loop [high-ceiling] diuretics
0.078 0.922 0.000
T50.0 Mineralocorticoids and their antagonists
0.078 0.922 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.077 0.922 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.077 0.923 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.067 0.932 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.054 0.945 0.001
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.052 0.948 0.000
T39.4 Antirheumatics, not elsewhere classified
0.037 0.963 0.000
T39.2 Pyrazolone derivatives
0.037 0.963 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.036 0.963 0.001
T39.0 Salicylates
0.035 0.965 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.034 0.966 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.033 0.967 0.000
M54.16 Radiculopathy (Lumbar region)
0.030 0.970 0.000
F52.2 Failure of genital response
0.000 0.970 0.030
M79.8 Other specified soft tissue disorders
0.000 0.970 0.030
T50.9 Other and unspecified drugs, medicaments and biological substances
0.029 0.971 0.000
M79.85 Other specified soft tissue disorders (Pelvic region and thigh)
0.000 0.971 0.029
M79.82 Other specified soft tissue disorders (Upper arm)
0.000 0.971 0.029
M79.84 Other specified soft tissue disorders (Hand)
0.000 0.973 0.027
M79.83 Other specified soft tissue disorders (Forearm)
0.000 0.974 0.026
M79.87 Other specified soft tissue disorders (Ankle and foot)
0.000 0.975 0.025
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.025 0.975 0.000
M79.88 Other specified soft tissue disorders (Other)
0.000 0.977 0.023
M79.80 Other specified soft tissue disorders (Multiple sites)
0.000 0.977 0.023
T39.1 4-Aminophenol derivatives
0.022 0.978 0.000
M79.81 Other specified soft tissue disorders (Shoulder region)
0.000 0.979 0.021
M79.86 Other specified soft tissue disorders (Lower leg)
0.000 0.980 0.020
Z50.7 Occupational therapy and vocational rehabilitation, not elsewhere classified
0.000 0.980 0.020
F52 Sexual dysfunction, not caused by organic disorder or disease
0.000 0.982 0.017
M79.89 Other specified soft tissue disorders (Site unspecified)
0.000 0.984 0.016
F52.0 Lack or loss of sexual desire
0.000 0.987 0.013
F52.9 Unspecified sexual dysfunction, not caused by organic disorder or disease
0.000 0.987 0.013
F52.8 Other sexual dysfunction, not caused by organic disorder or disease
0.000 0.987 0.013
F52.7 Excessive sexual drive
0.000 0.987 0.013
F52.6 Nonorganic dyspareunia
0.000 0.987 0.013
F52.5 Nonorganic vaginismus
0.000 0.987 0.013
F52.4 Premature ejaculation
0.000 0.987 0.013
F52.3 Orgasmic dysfunction
0.000 0.987 0.013
F52.1 Sexual aversion and lack of sexual enjoyment
0.000 0.987 0.013
R01.1 Cardiac murmur, unspecified
0.000 0.988 0.012
N88.2 Stricture and stenosis of cervix uteri
0.010 0.990 0.000
Z43.3 Attention to colostomy
0.000 0.991 0.009
I69.0 Sequelae of subarachnoid haemorrhage
0.009 0.991 0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.001 0.991 0.008
R01 Cardiac murmurs and other cardiac sounds
0.000 0.992 0.008
R01.0 Benign and innocent cardiac murmurs
0.000 0.992 0.008
G44.2 Tension-type headache
0.000 0.992 0.008
F50 Eating disorders
0.000 0.993 0.007
N02.9 Unspecified
0.000 0.993 0.007
F51 Nonorganic sleep disorders
0.000 0.993 0.006
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
0.001 0.994 0.006
F55 Abuse of non-dependence-producing substances
0.001 0.994 0.006
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
0.001 0.994 0.006
N41.1 Chronic prostatitis
0.006 0.994 0.000
F50.0 Anorexia nervosa
0.000 0.994 0.006
R01.2 Other cardiac sounds
0.000 0.994 0.006
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.001 0.994 0.005
F20.9 Schizophrenia, unspecified
0.006 0.994 0.000
Z43 Attention to artificial openings
0.000 0.994 0.006
Z43.4 Attention to other artificial openings of digestive tract
0.000 0.995 0.005
G44 Other headache syndromes
0.000 0.995 0.005
F51.5 Nightmares
0.000 0.995 0.005
F50.8 Other eating disorders
0.000 0.995 0.005
F50.5 Vomiting associated with other psychological disturbances
0.000 0.995 0.005
F50.4 Overeating associated with other psychological disturbances
0.000 0.995 0.005
F50.3 Atypical bulimia nervosa
0.000 0.995 0.005
F50.1 Atypical anorexia nervosa
0.000 0.995 0.005
F50.9 Eating disorder, unspecified
0.000 0.995 0.005
Z43.0 Attention to tracheostomy
0.000 0.995 0.005
H74.8 Other specified disorders of middle ear and mastoid
0.000 0.995 0.005
F51.3 Sleepwalking [somnambulism]
0.000 0.995 0.005
G44.0 Cluster headache syndrome
0.000 0.995 0.005
M54.1 Radiculopathy
0.005 0.995 0.000
F51.9 Nonorganic sleep disorder, unspecified
0.000 0.995 0.005
F51.8 Other nonorganic sleep disorders
0.000 0.995 0.005
F51.2 Nonorganic disorder of the sleep-wake schedule
0.000 0.995 0.005
F51.1 Nonorganic hypersomnia
0.000 0.995 0.005
F51.4 Sleep terrors [night terrors]
0.000 0.995 0.004
F51.0 Nonorganic insomnia
0.000 0.995 0.004
G44.8 Other specified headache syndromes
0.000 0.995 0.005
K00.6 Disturbances in tooth eruption
0.000 0.995 0.005
S42.40 Fracture of lower end of humerus (closed)
0.000 0.995 0.005
Z43.5 Attention to cyctostomy
0.000 0.995 0.005
N02 Recurrent and persistent haematuria
0.000 0.995 0.005
F53.9 Puerperal mental disorder, unspecified
0.001 0.995 0.004
F53.8 Other mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.001 0.995 0.004
F53.1 Severe mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.001 0.995 0.004
F50.2 Bulimia nervosa
0.001 0.996 0.004
Z43.8 Attention to other artificial openings
0.000 0.996 0.004
Z86.1 Personal history of infectious and parasitic diseases
0.000 0.996 0.004
Z43.1 Attention to gastrostomy
0.000 0.996 0.004
G44.1 Vascular headache, not elsewhere classified
0.000 0.996 0.004
Z43.9 Attention to unspecified artificial opening
0.000 0.996 0.004
Z43.7 Attention to artificial vagina
0.000 0.996 0.004
G44.4 Drug-induced headache, not elsewhere classified
0.000 0.996 0.004
H74 Other disorders of middle ear and mastoid
0.000 0.996 0.004
N02.8 Other
0.000 0.996 0.004
F53.0 Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.001 0.996 0.003
M54.17 Radiculopathy (Lumbosacral region)
0.004 0.996 0.000
H74.0 Tympanosclerosis
0.000 0.996 0.004
M54.15 Radiculopathy (Thoracolumbar region)
0.004 0.996 0.000
M54.13 Radiculopathy (Cervicothoracic region)
0.004 0.996 0.000
M54.11 Radiculopathy (Occipito-atlanto-axial region)
0.004 0.996 0.000
M54.10 Radiculopathy (Multiple sites in spine)
0.004 0.996 0.000
F20 Schizophrenia
0.004 0.996 0.000
H74.4 Polyp of middle ear
0.000 0.996 0.004
L92.3 Foreign body granuloma of skin and subcutaneous tissue
0.000 0.996 0.004
N12 Tubulo-interstitial nephritis, not specified as acute or chronic
0.004 0.996 0.000
H74.2 Discontinuity and dislocation of ear ossicles
0.000 0.996 0.004
Z43.6 Attention to other artificial openings of urinary tract
0.000 0.996 0.004
Z50.4 Psychotherapy, not elsewhere classified
0.000 0.996 0.004
H74.1 Adhesive middle ear disease
0.000 0.996 0.004
H26.8 Other specified cataract
0.000 0.996 0.004
M54.18 Radiculopathy (Sacral and sacrococcygeal region)
0.004 0.996 0.000
M54.12 Radiculopathy (Cervical region)
0.003 0.996 0.000
N05.9 Unspecified
0.000 0.996 0.004
N02.7 Diffuse crescentic glomerulonephritis
0.000 0.996 0.003
N02.6 Dense deposit disease
0.000 0.996 0.003
N02.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.996 0.003
N02.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.996 0.003
N02.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.996 0.003
N02.0 Minor glomerular abnormality
0.000 0.997 0.003
M47.89 Other spondylosis (Site unspecified)
0.000 0.997 0.003
F20.8 Other schizophrenia
0.003 0.997 0.000
Z50.0 Cardiac rehabilitation
0.000 0.997 0.003
F25.9 Schizoaffective disorder, unspecified
0.003 0.997 0.000
Z50 Care involving use of rehabilitation procedures
0.000 0.997 0.003
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.997 0.003
O32.1 Maternal care for breech presentation
0.003 0.997 0.000
Q12.0 Congenital cataract
0.000 0.997 0.003
M54.14 Radiculopathy (Thoracic region)
0.003 0.997 0.000
G44.3 Chronic posttraumatic headache
0.000 0.997 0.003
N05.1 Focal and segmental glomerular lesions
0.000 0.997 0.003
N05 Unspecified nephritic syndrome
0.000 0.997 0.003
H90.5 Sensorineural hearing loss, unspecified
0.000 0.997 0.003
R10.2 Pelvic and perineal pain
0.003 0.997 0.000
F25 Schizoaffective disorders
0.003 0.997 0.000
N00-N08 Glomerular diseases
0.000 0.997 0.003
F20.6 Simple schizophrenia
0.003 0.997 0.000
F20.4 Postschizophrenic depression
0.003 0.997 0.000
F20.3 Undifferentiated schizophrenia
0.003 0.997 0.000
F20.2 Catatonic schizophrenia
0.003 0.997 0.000
F20.1 Hebephrenic schizophrenia
0.003 0.997 0.000
N02.2 Diffuse membranous glomerulonephritis
0.000 0.997 0.003
Z57.3 Occupational exposure to other air contaminants
0.000 0.997 0.003
L92 Granulomatous disorders of skin and subcutaneous tissue
0.000 0.997 0.003
M45.X9 Ankylosing spondylitis (Site unspecified)
0.000 0.997 0.003
N02.1 Focal and segmental glomerular lesions
0.000 0.997 0.003
O32.8 Maternal care for other malpresentation of foetus
0.003 0.997 0.000
R74.8 Abnormal levels of other serum enzymes
0.000 0.997 0.003
N04 Nephrotic syndrome
0.000 0.997 0.003
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.003 0.997 0.000
L92.9 Granulomatous disorder of skin and subcutaneous tissue, unspecified
0.000 0.997 0.003
O32.5 Maternal care for multiple gestation with malpresentation of one foetus or more
0.003 0.997 0.000
H90.3 Sensorineural hearing loss, bilateral
0.000 0.997 0.003
L05.9 Pilonidal cyst without abscess
0.003 0.997 0.000
R45.1 Restlessness and agitation
0.000 0.997 0.003
N04.1 Focal and segmental glomerular lesions
0.000 0.997 0.003
L92.0 Granuloma annulare
0.000 0.997 0.003
Y45.1 Salicylates
0.000 0.997 0.003
F99 Mental disorder, not otherwise specified
0.003 0.997 0.000
F40.2 Specific (isolated) phobias
0.003 0.997 0.000
N05.7 Diffuse crescentic glomerulonephritis
0.000 0.997 0.003
L92.2 Granuloma faciale [eosinophilic granuloma of skin]
0.000 0.997 0.003
M54.19 Radiculopathy (Site unspecified)
0.002 0.997 0.000
I05.0 Mitral stenosis
0.000 0.997 0.003
R60.0 Localised oedema
0.000 0.997 0.003
O32 Maternal care for known or suspected malpresentation of foetus
0.003 0.997 0.000
M20.5 Other deformities of toe(s) (acquired)
0.003 0.997 0.000
N04.9 Unspecified
0.000 0.997 0.003
Z50.6 Orthoptic training
0.000 0.997 0.003
F25.2 Schizoaffective disorder, mixed type
0.003 0.997 0.000
F25.0 Schizoaffective disorder, manic type
0.003 0.997 0.000
Z50.3 Drug rehabilitation
0.000 0.997 0.003
L92.8 Other granulomatous disorders of skin and subcutaneous tissue
0.000 0.997 0.003
N03 Chronic nephritic syndrome
0.000 0.997 0.003
F20.5 Residual schizophrenia
0.002 0.997 0.000
F20.0 Paranoid schizophrenia
0.003 0.997 0.000
N05.6 Dense deposit disease
0.000 0.997 0.002
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.997 0.002
N05.0 Minor glomerular abnormality
0.000 0.997 0.002
H90 Conductive and sensorineural hearing loss
0.000 0.997 0.003
F25.8 Other schizoaffective disorders
0.002 0.997 0.000
W55.0 Home
0.003 0.997 0.000
N07 Hereditary nephropathy, not elsewhere classified
0.000 0.997 0.002
N06 Isolated proteinuria with specified morphological lesion
0.000 0.997 0.002
N01 Rapidly progressive nephritic syndrome
0.000 0.997 0.002
R06.2 Wheezing
0.003 0.997 0.000
L92.1 Necrobiosis lipoidica, not elsewhere classified
0.000 0.997 0.002
K06.8 Other specified disorders of gingiva and edentulous alveolar ridge
0.000 0.998 0.002
N04.0 Minor glomerular abnormality
0.000 0.998 0.002
N04.8 Other
0.000 0.998 0.002
N04.7 Diffuse crescentic glomerulonephritis
0.000 0.998 0.002
N04.6 Dense deposit disease
0.000 0.998 0.002
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.998 0.002
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.998 0.002
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.998 0.002
H74.9 Disorder of middle ear and mastoid, unspecified
0.000 0.998 0.002
N00 Acute nephritic syndrome
0.000 0.998 0.002
Y45.2 Propionic acid derivatives
0.000 0.998 0.002
N04.2 Diffuse membranous glomerulonephritis
0.000 0.998 0.002
F23 Acute and transient psychotic disorders
0.002 0.998 0.000
F28 Other nonorganic psychotic disorders
0.002 0.998 0.000
F24 Induced delusional disorder
0.002 0.998 0.000
F21 Schizotypal disorder
0.002 0.998 0.000
Z50.8 Care involving use of rehabilitation procedures
0.000 0.998 0.002
N88 Other noninflammatory disorders of cervix uteri
0.002 0.998 0.000
K51.2 Ulcerative (chronic) proctitis
0.002 0.998 0.000
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.998 0.002
F60.3 Emotionally unstable personality disorder
0.002 0.998 0.000
I05.2 Mitral stenosis with insufficiency
0.000 0.998 0.002
N05.2 Diffuse membranous glomerulonephritis
0.000 0.998 0.002
F23.3 Other acute predominantly delusional psychotic disorders
0.002 0.998 0.000
H74.3 Other acquired abnormalities of ear ossicles
0.000 0.998 0.002
O32.0 Maternal care for unstable lie
0.002 0.998 0.000
F25.1 Schizoaffective disorder, depressive type
0.002 0.998 0.000
N03.9 Unspecified
0.000 0.998 0.002
Y45.5 4-Aminophenol derivatives
0.000 0.998 0.002
Z39.0 Care and examination immediately after delivery
0.000 0.998 0.002
N81.8 Other female genital prolapse
0.000 0.998 0.002
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.998 0.002
I09.9 Rheumatic heart disease, unspecified
0.000 0.998 0.002
N03.1 Focal and segmental glomerular lesions
0.000 0.998 0.002
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.000 0.998 0.002
M45.X0 Ankylosing spondylitis (Multiple sites in spine)
0.000 0.998 0.002
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.998 0.002
S42.4 Fracture of lower end of humerus
0.000 0.998 0.002
K06.9 Disorder of gingiva and edentulous alveolar ridge, unspecified
0.000 0.998 0.002
F22 Persistent delusional disorders
0.002 0.998 0.000
G95.9 Disease of spinal cord, unspecified
0.002 0.998 0.000
Z42.1 Follow-up care involving plastic surgery of breast
0.000 0.998 0.002
F29 Unspecified nonorganic psychosis
0.002 0.998 0.000
M23.61 Other spontaneous disruption of ligament(s) of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)
0.000 0.998 0.002
N03.7 Diffuse crescentic glomerulonephritis
0.000 0.998 0.002
N03.6 Dense deposit disease
0.000 0.998 0.002
N03.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.998 0.002
N03.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.998 0.002
N03.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.998 0.002
N03.2 Diffuse membranous glomerulonephritis
0.000 0.998 0.002
N03.0 Minor glomerular abnormality
0.000 0.998 0.002
Y53.1 Other antacids and anti-gastric-secretion drugs
0.000 0.998 0.002
I05 Rheumatic mitral valve diseases
0.000 0.998 0.002
N88.4 Hypertrophic elongation of cervix uteri
0.002 0.998 0.000
O32.3 Maternal care for face, brow and chin presentation
0.002 0.998 0.000
Z57.2 Occupational exposure to dust
0.000 0.998 0.002
O32.2 Maternal care for transverse and oblique lie
0.002 0.998 0.000
K90.0 Coeliac disease
0.000 0.998 0.002
N01.9 Unspecified
0.000 0.998 0.002
N01.8 Other
0.000 0.998 0.002
N01.7 Diffuse crescentic glomerulonephritis
0.000 0.998 0.002
N01.6 Dense deposit disease
0.000 0.998 0.002
N01.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.998 0.002
N01.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.998 0.002
N01.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.998 0.002
N01.2 Diffuse membranous glomerulonephritis
0.000 0.998 0.002
N01.1 Focal and segmental glomerular lesions
0.000 0.998 0.002
N01.0 Minor glomerular abnormality
0.000 0.998 0.002
N06.9 Unspecified
0.000 0.998 0.002
N06.8 Other
0.000 0.998 0.002
N06.7 Diffuse crescentic glomerulonephritis
0.000 0.998 0.002
N06.6 Dense deposit disease
0.000 0.998 0.002
N06.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.998 0.002
N06.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.998 0.002
N06.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.998 0.002
N06.2 Diffuse membranous glomerulonephritis
0.000 0.998 0.002
N06.1 Focal and segmental glomerular lesions
0.000 0.998 0.002
N06.0 Minor glomerular abnormality
0.000 0.998 0.002
N07.9 Unspecified
0.000 0.998 0.002
N07.8 Other
0.000 0.998 0.002
N07.7 Diffuse crescentic glomerulonephritis
0.000 0.998 0.002
N07.6 Dense deposit disease
0.000 0.998 0.002
N07.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.998 0.002
N07.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.998 0.002
N07.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.998 0.002
N07.2 Diffuse membranous glomerulonephritis
0.000 0.998 0.002
N07.1 Focal and segmental glomerular lesions
0.000 0.998 0.002
N07.0 Minor glomerular abnormality
0.000 0.998 0.002
S40.0 Contusion of shoulder and upper arm
0.000 0.998 0.002
Q12 Congenital lens malformations
0.000 0.998 0.002
M45 Ankylosing spondylitis
0.000 0.998 0.002
F60 Specific personality disorders
0.002 0.998 0.000
F60.2 Dissocial personality disorder
0.002 0.998 0.000
N00.8 Other
0.000 0.998 0.002
N00.7 Diffuse crescentic glomerulonephritis
0.000 0.998 0.002
N00.6 Dense deposit disease
0.000 0.998 0.002
N00.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.998 0.002
N00.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.998 0.002
N00.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.998 0.002
N00.2 Diffuse membranous glomerulonephritis
0.000 0.998 0.002
N00.1 Focal and segmental glomerular lesions
0.000 0.998 0.002
N00.0 Minor glomerular abnormality
0.000 0.998 0.002
O32.9 Maternal care for malpresentation of foetus, unspecified
0.002 0.998 0.000
O63.1 Prolonged second stage (of labour)
0.000 0.998 0.002
F23.8 Other acute and transient psychotic disorders
0.002 0.998 0.000
F23.2 Acute schizophrenia-like psychotic disorder
0.002 0.998 0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia
0.002 0.998 0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia
0.002 0.998 0.000
I22.9 Subsequent myocardial infarction of unspecified site
0.000 0.998 0.002
N05.8 Other
0.000 0.998 0.002
N88.0 Leukoplakia of cervix uteri
0.002 0.998 0.000
O32.6 Maternal care for compound presentation
0.002 0.998 0.000
E21.3 Hyperparathyroidism, unspecified
0.002 0.998 0.000
F81.9 Developmental disorder of scholastic skills, unspecified
0.002 0.998 0.000
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.998 0.002
H90.8 Mixed conductive and sensorineural hearing loss, unspecified
0.000 0.998 0.002
H90.0 Conductive hearing loss, bilateral
0.000 0.998 0.002
Z50.9 Care involving use of rehabilitation procedure, unspecified
0.000 0.998 0.002
Z99.8 Dependence on other enabling machines and devices
0.000 0.998 0.002
M79.28 Neuralgia and neuritis, unspecified (Other)
0.000 0.998 0.002
Y45.8 Other analgesics and antipyretics
0.000 0.998 0.002
Z57 Occupational exposure to risk-factors
0.000 0.998 0.002
F99-F99 Unspecified mental disorder
0.002 0.998 0.000
M85.64 Other cyst of bone (Hand)
0.002 0.998 0.000
I05.9 Mitral valve disease, unspecified
0.000 0.998 0.002
I87.2 Venous insufficiency (chronic) (peripheral)
0.002 0.998 0.000
N00.9 Unspecified
0.000 0.998 0.002
N88.3 Incompetence of cervix uteri
0.002 0.998 0.000
F60.5 Anankastic personality disorder
0.002 0.998 0.000
N03.8 Other
0.000 0.998 0.002
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.000 0.998 0.002
G95.8 Other specified diseases of spinal cord
0.002 0.998 0.000
S19.9 Unspecified injury of neck
0.000 0.998 0.002
Y45.4 Antirheumatics
0.000 0.998 0.002
F22.8 Other persistent delusional disorders
0.002 0.998 0.000
M45.X6 Ankylosing spondylitis (Lumbar region)
0.000 0.998 0.002
N88.9 Noninflammatory disorder of cervix uteri, unspecified
0.002 0.998 0.000
N88.1 Old laceration of cervix uteri
0.002 0.998 0.000
I05.8 Other mitral valve diseases
0.000 0.998 0.002
J44.0 Chronic obstructive pulmonary disease with acute lower respiratory infection
0.000 0.998 0.002
K00 Disorders of tooth development and eruption
0.000 0.998 0.002
I51.9 Heart disease, unspecified
0.000 0.998 0.002
F60.0 Paranoid personality disorder
0.002 0.998 0.000
Q12.9 Congenital lens malformation, unspecified
0.000 0.998 0.002
Q12.8 Other congenital lens malformations
0.000 0.998 0.002
Q12.4 Spherophakia
0.000 0.998 0.002
Q12.3 Congenital aphakia
0.000 0.998 0.002
Q12.2 Coloboma of lens
0.000 0.998 0.002
Q12.1 Congenital displaced lens
0.000 0.998 0.002
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters
0.000 0.998 0.002
F10.6 Amnesic syndrome
0.002 0.998 0.000
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)
0.000 0.998 0.002
M45.X7 Ankylosing spondylitis (Lumbosacral region)
0.000 0.998 0.002
M45.X5 Ankylosing spondylitis (Thoracolumbar region)
0.000 0.998 0.002
M45.X4 Ankylosing spondylitis (Thoracic region)
0.000 0.998 0.002
M45.X3 Ankylosing spondylitis (Cervicothoracic region)
0.000 0.998 0.002
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)
0.000 0.998 0.002
F60.4 Histrionic personality disorder
0.002 0.998 0.000
F60.1 Schizoid personality disorder
0.002 0.998 0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.998 0.002
O32.4 Maternal care for high head at term
0.002 0.998 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.998 0.002
Z76.8 Persons encountering health services in other specified circumstances
0.000 0.998 0.002
F61 Mixed and other personality disorders
0.002 0.998 0.000
Z57.8 Occupational exposure to other risk-factors
0.000 0.998 0.002
N08 Glomerular disorders in diseases classified elsewhere
0.000 0.998 0.002
C10.9 Oropharynx, unspecified
0.000 0.998 0.002
F22.0 Delusional disorder
0.002 0.998 0.000
F60.6 Anxious [avoidant] personality disorder
0.002 0.998 0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral
0.000 0.998 0.002
M45.X2 Ankylosing spondylitis (Cervical region)
0.000 0.998 0.002
G95 Other diseases of spinal cord
0.002 0.998 0.000
F60-F69 Disorders of adult personality and behaviour
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.